Dr. Desantes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
600 Highland Ave
Madison, WI 53792Phone+1 608-263-6420Fax+1 608-263-0440- Is this information wrong?
Education & Training
- University of WashingtonFellowship, Pediatric Hematology/Oncology, 1987 - 1990
- Children's Hospital Los AngelesResidency, Pediatrics, 1984 - 1987
- New York Medical CollegeClass of 1984
- University of MichiganMS, Immunology, 1979 - 1980
Certifications & Licensure
- CA State Medical License 1986 - Present
- WI State Medical License 1998 - 2025
- WA State Medical License 1987 - 1991
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Endowed Chair Crawford Professor of Pediatric Oncology, 2016
- UW Physicians Clinical Service Excellence Award University of Wisconsin, 2013
Clinical Trials
- Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
- Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors Start of enrollment: 2004 Mar 22
- Haploidentical Transplant With NK Cell Infusion for Pediatric Acute Leukemia and Solid Tumors Start of enrollment: 2008 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Posttransplantation late complications increase over time for patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) landmark study.Eissa, H., Thakar, M., Shah, A., Logan, B., Griffith, L., Dong, H., Parrott, R., O'Reilly, R., Dara, J., Kapoor, N., Forbes Satter, L., Chandra, S., Kapadia, M., Chand...> ;The Journal of Allergy and Clinical Immunology. 2024 Jan 1
- 3 citationsGenotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD.Leiding, J., Arnold, D., Parikh, S., Logan, B., Marsh, R., Griffith, L., Wu, R., Kidd, S., Mallhi, K., Chellapandian, D., Si Lim, S., Grunebaum, E., Falcone, E., Murgu...> ;Blood. 2023 Dec 14
- 7 citationsMeasuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from...Thakar, M., Logan, B., Puck, J., Dunn, E., Buckley, R., Cowan, M., O'Reilly, R., Kapoor, N., Satter, L., Pai, S., Heimall, J., Chandra, S., Ebens, C., Chellapandian, D...> ;Lancet. 2023 Jul 8
- Join now to see all
Grant Support
- Generation Of Cytoxic Activity Against Pediatric Solid TumorsNational Center For Research Resources1998–2002
Hospital Affiliations
- University HospitalMadison, Wisconsin
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: